Social determinants of health (SDOH) profoundly influence cancer outcomes. Disparities in these areas contribute to delayed diagnoses, limited access to advanced treatments, and poorer survival rates, disproportionately affecting marginalized populations. While advancements in cancer care have improved survival, these benefits remain unevenly distributed. This review examines the impact of SDOH on cancer care across multiple domains. It highlights the ways in which structural barriers exacerbate disparities in prevention, diagnosis, and treatment. Evidence-based interventions, including Medicaid expansion, culturally tailored patient navigation programs, increased diversity in clinical trials, telemedicine expansion, and the integration of SDOH screening into oncology workflows—offer promising strategies for addressing these inequities. By integrating these strategies into clinical practice and health policy, the healthcare system can foster a more just and inclusive future for cancer treatment and survivorship.
健康的社会决定因素（SDOH）对癌症结局具有深远影响。这些领域的差异导致诊断延迟、先进治疗手段获取受限以及生存率降低，对边缘化群体的影响尤为显著。尽管癌症治疗技术的进步提升了整体生存率，但这些获益的分布并不均衡。本文综述探讨了SDOH在多个维度对癌症诊疗的影响，重点分析了结构性障碍如何加剧预防、诊断和治疗过程中的不平等现象。基于循证医学的干预措施——包括医疗补助计划扩展、文化适配的患者导航项目、临床试验多样性提升、远程医疗推广以及将SDOH筛查纳入肿瘤诊疗流程——为应对这些不平等问题提供了可行策略。通过将这些策略融入临床实践与卫生政策，医疗体系有望构建更加公正、包容的癌症治疗与生存支持体系。
From Diagnosis to Survivorship: The Role of Social Determinants in Cancer Care
肿瘤(癌症)患者之家